Enhanced UV Technology Improves Hospital Infection Prevention
By HospiMedica International staff writers Posted on 09 Jun 2014 |

Image: The TRU-D SmartUVC with iTRU-D in action (Photo courtesy of TRU-D).
An upgraded Ultraviolet C band (UV-C) disinfection robot performs automated pathogen disinfection of patient spaces.
The TRU-D SmartUVC with iTRU-D exploits Sensor360 technology for instant room analysis and dose calculation and delivery, eliminating the need to input room measurements, floor plans or diagrams needed to designate multiple robot positions, and increased labor costs due to the need to cover windows and vents. As a result, the TRU-D is able to disinfect an entire room—including shadowed spaces—from one location within the room, eliminating labor associated with continually moving it to multiple sites inside the room. The disinfection progress also ensures 3–4 log surface disinfection of pathogens in any space.
Cloud-based infection prevention data tracking technology provided by iTRU-D reports concurrent prevention, usage efficiency, and risk aversion data. The secure usage-tracking program also sends customized real-time infection prevention reports via an iPad Mini to hospital staff. Among the other features of the system are dose assurance delivered to direct and shadowed high touch surfaces, rapid room disinfection, and environmental safety, since UVC light is not transmitted through glass windows. The TRU-D SmartUVC portable disinfection robot with iTRU-D is a product of TRU-D (Memphis, TN, USA).
“We work closely with our customers to provide a product that fits their infection prevention needs. Second to providing an evidence base for consistent disinfection outcomes to insure patient safety, labor cost is the major consideration in the selection of no-touch room disinfection technology,” said Chuck Dunn, president of TRU-D. “TRU-D is validated by numerous third-party scientific studies proving that TRU-D's patented technology works to eradicate 99.9% of pathogens, which is what's most important to health care customers.”
UV-C light is a UV wavelength of 254 nm that induces the formation of pyrimidine dimers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, thus destroying the organisms or rendering them unable to reproduce. The efficacy of the UV-C irradiation is a function of many different parameters, such as intensity, exposure time, lamp placement, and air movement patterns.
Related Links:
TRU-D
The TRU-D SmartUVC with iTRU-D exploits Sensor360 technology for instant room analysis and dose calculation and delivery, eliminating the need to input room measurements, floor plans or diagrams needed to designate multiple robot positions, and increased labor costs due to the need to cover windows and vents. As a result, the TRU-D is able to disinfect an entire room—including shadowed spaces—from one location within the room, eliminating labor associated with continually moving it to multiple sites inside the room. The disinfection progress also ensures 3–4 log surface disinfection of pathogens in any space.
Cloud-based infection prevention data tracking technology provided by iTRU-D reports concurrent prevention, usage efficiency, and risk aversion data. The secure usage-tracking program also sends customized real-time infection prevention reports via an iPad Mini to hospital staff. Among the other features of the system are dose assurance delivered to direct and shadowed high touch surfaces, rapid room disinfection, and environmental safety, since UVC light is not transmitted through glass windows. The TRU-D SmartUVC portable disinfection robot with iTRU-D is a product of TRU-D (Memphis, TN, USA).
“We work closely with our customers to provide a product that fits their infection prevention needs. Second to providing an evidence base for consistent disinfection outcomes to insure patient safety, labor cost is the major consideration in the selection of no-touch room disinfection technology,” said Chuck Dunn, president of TRU-D. “TRU-D is validated by numerous third-party scientific studies proving that TRU-D's patented technology works to eradicate 99.9% of pathogens, which is what's most important to health care customers.”
UV-C light is a UV wavelength of 254 nm that induces the formation of pyrimidine dimers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, thus destroying the organisms or rendering them unable to reproduce. The efficacy of the UV-C irradiation is a function of many different parameters, such as intensity, exposure time, lamp placement, and air movement patterns.
Related Links:
TRU-D
Latest Critical Care News
- Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
- Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
Channels
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more